Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The British Journal of Ophthalmology|November 30, 2021
Histopathology-guided management of ocular surface squamous neoplasia with corneal stromal or scleral invasion using ruthenium-106 plaque brachytherapyRaksha Rao, Santosh G Honavar, Sumeet Lahane, et al.
Ophthalmology|May 4, 2024
Intravitreal Topotecan for Vitreous Seeds in Retinoblastoma: A Long-term Review of 91 EyesMrittika Sen, Raksha Rao, Kaustubh Mulay, et al.
Indian Journal of Ophthalmology|January 31, 2018
Melanorrhea: Noncontiguous spread of palpebral conjunctival melanoma to the nasolacrimal ductRaksha Rao, Santosh G Honavar, Michelle De Padua, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|July 10, 2018
Optical Coherence Tomography of Small RetinoblastomaR Joel Welch, Raksha Rao, Phillip S Gordon, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 6, 2017
Protective effects of phenolics rich extract of ginger against Aflatoxin B<sub>1</sub>-induced oxidative stress and hepatotoxicityVipin A V, Raksha Rao K, Nawneet Kumar Kurrey, et al.
Genes|July 27, 2022
Integrated Transcriptome and Metabolomic Analysis Reveal Anti-Angiogenic Properties of Disarib, a Novel Bcl2-Specific InhibitorMeghana Manjunath, Sai Swaroop, Sai Sanwid Pradhan, et al.
Journal of Pediatric Ophthalmology and Strabismus|July 21, 2020
Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 PatientsLauren A Dalvin, Zeynep Bas, Sameeksha Tadepalli, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|January 22, 2021
Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma Based on Patient Age in 964 Eyes of 554 PatientsZeynep Bas, Lauren A Dalvin, Sameeksha Tadepalli, et al.
3 Biotech|February 28, 2023
Vitamin B<sub>6,</sub> B<sub>12</sub> and folate modulate deregulated pathways and protein aggregation in yeast model of Huntington diseaseSai Sanwid Pradhan, K Raksha Rao, Meghana Manjunath, et al.
Oman Journal of Ophthalmology|November 13, 2025
Serum vascular endothelial growth factor in patients with nonmelanoma primary ocular malignancies: A possible potential biomarker of tumor progression and poor prognosisRajendra Prakash Maurya, Anjali Singh, Virendra Pratap Singh, et al.
Pageof 4